<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11</volume><submitter>Shen-Gunther J</submitter><funding>Brooke Army Medical Center</funding><pubmed_abstract>Primary high-risk Human Papillomavirus (hrHPV) screening has recently become an accepted standalone or co-test with conventional cytology. Unfortunately, hrHPV singularly lacks specificity for cytopathological grade. However, mechanisms and markers of evolving virus-host interactions at the epigenome level may be harnessed as a better predictor of carcinogenesis. This study aimed to validate and expand the clinical performance of a multiparametric biomarker panel, referred to as the "Molecular Pap smear" based, on HPV genotype and &lt;i>ADCY8&lt;/i>, &lt;i>CDH8&lt;/i> and &lt;i>ZNF582&lt;/i> CpG-methylation as a predictive classifier of cervical cytology. This prospective, cross-sectional study used an independent cohort of residual liquid-based cytology for HPV genotyping and epigenetic analysis. Extracted</pubmed_abstract><journal>Frontiers in microbiology</journal><pagination>595902</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7593258</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Molecular Pap Smear: Validation of HPV Genotype and Host Methylation Profiles of &lt;i>ADCY8&lt;/i>, &lt;i>CDH8&lt;/i>, and &lt;i>ZNF582&lt;/i> as a Predictor of Cervical Cytopathology.</pubmed_title><pmcid>PMC7593258</pmcid><pubmed_authors>Asusta HB</pubmed_authors><pubmed_authors>Stacey W</pubmed_authors><pubmed_authors>Shen-Gunther J</pubmed_authors><pubmed_authors>Xia Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Molecular Pap Smear: Validation of HPV Genotype and Host Methylation Profiles of &lt;i>ADCY8&lt;/i>, &lt;i>CDH8&lt;/i>, and &lt;i>ZNF582&lt;/i> as a Predictor of Cervical Cytopathology.</name><description>Primary high-risk Human Papillomavirus (hrHPV) screening has recently become an accepted standalone or co-test with conventional cytology. Unfortunately, hrHPV singularly lacks specificity for cytopathological grade. However, mechanisms and markers of evolving virus-host interactions at the epigenome level may be harnessed as a better predictor of carcinogenesis. This study aimed to validate and expand the clinical performance of a multiparametric biomarker panel, referred to as the "Molecular Pap smear" based, on HPV genotype and &lt;i>ADCY8&lt;/i>, &lt;i>CDH8&lt;/i> and &lt;i>ZNF582&lt;/i> CpG-methylation as a predictive classifier of cervical cytology. This prospective, cross-sectional study used an independent cohort of residual liquid-based cytology for HPV genotyping and epigenetic analysis. Extracted</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2026-07-09T11:19:36.07Z</modification><creation>2020-11-19T11:39:22Z</creation></dates><accession>S-EPMC7593258</accession><cross_references><pubmed>33178175</pubmed><doi>10.3389/fmicb.2020.595902</doi></cross_references></HashMap>